Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Melero

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 24, 2021
Harmful cytokines in cancer immunology and immunotherapy: biomarkers and targets?I Melero, N Normanno
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 11, 2020
Revisiting anti-CTLA-4 antibodies in combination with PD-1 blockade for cancer immunotherapyM Sznol, I Melero
Life Sciences|January 1, 1997
Costimulation, tolerance and ignorance of cytolytic T lymphocytes in immune responses to tumor antigensI Melero, N Bach, L Chen
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2017
Cancer immunotherapy full speed aheadI Melero, B Navarro, A Teijeira, et al.
Gene Therapy|August 3, 2000
Feeding dendritic cells with tumor antigens: self-service buffet or à la carte?I Melero, R G Vile, M P Colombo
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2016
Defining the optimal murine models to investigate immune checkpoint blockers and their combination with other immunotherapiesM F Sanmamed, C Chester, I Melero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 30, 2024
Reply to the Letter to the Editor "Reflections on the statistical methodology in nivolumab and ipilimumab therapy research" by S. YangI Melero, S Soleymani, M Tschaika, et al.
Revista De Enfermeria (Barcelona, Spain)|May 8, 2000
[Nursing care in osteoporosis. Health education and primary care]M R Fernández García, R M García Jorge, I Melero Pellicer
Trends in Immunology|April 5, 2001
IL-12 gene therapy for cancer: in synergy with other immunotherapiesI Melero, G Mazzolini, I Narvaiza, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1994
Tyrosine kinase-dependent activation of human NK cell functions upon stimulation through a 58-kDa surface antigen selectively expressed on discrete subsets of NK cells and T lymphocytesI Melero, A Salmerón, M A Balboa, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 24, 2021
Harmful cytokines in cancer immunology and immunotherapy: biomarkers and targets?I Melero, N Normanno
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 11, 2020
Revisiting anti-CTLA-4 antibodies in combination with PD-1 blockade for cancer immunotherapyM Sznol, I Melero
Life Sciences|January 1, 1997
Costimulation, tolerance and ignorance of cytolytic T lymphocytes in immune responses to tumor antigensI Melero, N Bach, L Chen
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2017
Cancer immunotherapy full speed aheadI Melero, B Navarro, A Teijeira, et al.
Gene Therapy|August 3, 2000
Feeding dendritic cells with tumor antigens: self-service buffet or à la carte?I Melero, R G Vile, M P Colombo
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2016
Defining the optimal murine models to investigate immune checkpoint blockers and their combination with other immunotherapiesM F Sanmamed, C Chester, I Melero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 30, 2024
Reply to the Letter to the Editor "Reflections on the statistical methodology in nivolumab and ipilimumab therapy research" by S. YangI Melero, S Soleymani, M Tschaika, et al.
Revista De Enfermeria (Barcelona, Spain)|May 8, 2000
[Nursing care in osteoporosis. Health education and primary care]M R Fernández García, R M García Jorge, I Melero Pellicer
Trends in Immunology|April 5, 2001
IL-12 gene therapy for cancer: in synergy with other immunotherapiesI Melero, G Mazzolini, I Narvaiza, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1994
Tyrosine kinase-dependent activation of human NK cell functions upon stimulation through a 58-kDa surface antigen selectively expressed on discrete subsets of NK cells and T lymphocytesI Melero, A Salmerón, M A Balboa, et al.
Pageof 7